2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults

By afschroeder • April 2, 2026

Shumaker AH, Bhimraj A, Bedimo R, Cheng VC, Chew KW, Daar ES, Glidden DV, Shafer RW, Tien PC, Baden LR, Cawcutt K, Chiotos K, Dzierba AL, Hardy EJ, Johnson S, Kim AY, MacBrayne C, Martin GS, Nadig N, Nakamura MM, Oliveira CR, Pearson JC, Riley L, Shoham S, Tebas P, Willis Z, Wolf J, Loveless J, Morgan RL, Falck-Ytter Y, Gandhi RT. 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults. Clin Infect Dis. 2026 Apr 1:ciaf680. doi: 10.1093/cid/ciaf680. Epub ahead of print. PMID: 41920902.

Tags: covid-19, guideline, Harbor UCLA, Infectious Diseases, molnupiravir, nirmatrelvir/ritonavir, Publications, remdesivir

Heart failure and atrial fibrillation prediction from non-gated chest CT scans using AI-based cardiac chamber volumetry: an AI-CVD study within the multi-ethnic study of atherosclerosis (MESA)

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Ghaffari Jolfayi A, Atlas T, Henschke CI, Yankelevitz DF,[...]

Editorial: The experimental models as a tool for studying therapeutic targets in COPD: lessons learned

Degobbi T Q S Lopes F, Vieira RP, Abbasi A. Editorial: The experimental models as a tool for studying therapeutic targets in COPD: lessons learned.[...]

Comparison of AI-enabled cardiac chambers volumetry based on non-gated chest CT scans with echocardiography: An AI-CVD study within the Multi-Ethnic Study of Atherosclerosis (MESA)

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Ghaffari Jolfayi A, Atlas T, Henschke CI, Yankelevitz DF,[...]